Soliris (eculizumab) / Handok, AstraZeneca  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
NCT05863442: Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants

Recruiting
1
120
RoW
Soliris 300 MG in 30 ML Injection, TUR03 300 MG in 30 ML Injection
Turgut Ardika PTY LTD
Healthy
07/24
10/24

Download Options